Expertise in
15
conditions

Sophie Leboulleux

Gustave Roussy
Villejuif, FR 
Expertise in
15
conditions
Gustave Roussy
Villejuif, FR 

Overview

Sophie Leboulleux practices practicing medicine in Villejuif, France.

Ms. Leboulleux is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Medullary Thyroid Carcinoma, Adrenal Cancer, Thyroidectomy, and Liver Embolization.

She is actively involved in clinical research, co-authoring 192 peer reviewed articles and participating in 6 clinical trials.

Gender

Female

Locations

Gustave Roussy
Villejuif, 94805, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Randomized, Multicenter, Open-label, Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma
A Randomized, Multicenter, Open-label, Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma
Enrollment Status: Completed
Publish Date: July 02, 2026
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Randomized, Open-label, Phase 3 Trial Comparing Selpercatinib to Physicians Choice of Cabozantinib or Vandetanib in Patients With Progressive, Advanced, Kinase Inhibitor Naïve, RET-Mutant Medullary Thyroid Cancer (LIBRETTO-531)
A Multicenter, Randomized, Open-label, Phase 3 Trial Comparing Selpercatinib to Physicians Choice of Cabozantinib or Vandetanib in Patients With Progressive, Advanced, Kinase Inhibitor Naïve, RET-Mutant Medullary Thyroid Cancer (LIBRETTO-531)
Enrollment Status: Active_not_recruiting
Publish Date: March 19, 2026
Intervention Type: Drug
Study Drugs: Selpercatinib, Cabozantinib, Vandetanib
Study Phase: Phase 3
Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients?
Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients?
Enrollment Status: Active_not_recruiting
Publish Date: May 17, 2023
Intervention Type: Other, Drug
Study Drugs: rhTSH stimulation, I131
Study Phase: Phase 3
First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma (PPGL)
First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma (PPGL)
Enrollment Status: Completed
Publish Date: August 04, 2022
Intervention Type: Drug
Study Drug: Sunitinib
Study Phase: Phase 2
Single Arm Phase II Trial Evaluating the Efficacy of Radium 223 in Radioactive Iodine Refractory Bone Metastases From Differentiated Thyroid Cancer
Single Arm Phase II Trial Evaluating the Efficacy of Radium 223 in Radioactive Iodine Refractory Bone Metastases From Differentiated Thyroid Cancer
Enrollment Status: Completed
Publish Date: June 11, 2019
Intervention Type: Radiation
Study Phase: Phase 2
Utility of Recombinant Human Thyrotropin (rTSH) PET-CT Fusion Scanning to Identify Residual Well-differentiated Epithelial Thyroid Cancer
Utility of Recombinant Human Thyrotropin (rTSH) PET-CT Fusion Scanning to Identify Residual Well-differentiated Epithelial Thyroid Cancer
Enrollment Status: Completed
Publish Date: November 02, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

192 Total Publications

Autofluorescence enhances intraoperative detection of parathyroid glands: a single-center comparative study.
Autofluorescence enhances intraoperative detection of parathyroid glands: a single-center comparative study.
Journal: Frontiers in endocrinology
Published: January 15, 2026

Frequently Asked Questions about Sophie Leboulleux

Is Sophie Leboulleux a top-rated expert for Thyroid Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Sophie Leboulleux is classified as an Elite expert for Thyroid Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Sophie Leboulleux participate in research or clinical trials?

Yes. Sophie Leboulleux has published 192 articles and abstracts on conditions like Thyroid Cancer. You can view a list of Sophie Leboulleux's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Leboulleux's expertise for a condition
ConditionClose
View All 7 Distinguished Conditions
View All 23 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile